Dysregulation of both TFAP2C and PELP1 in ER+ BC suggests that modulation of the TFAP2C pathway by PELP1 may represent a potential mechanism by which PELP1 promotes breast tumorigenesis. The gene discussed is PELP1; the disease is breast cancer.